細胞表面標記檢測市場：按產品、按應用、按地區 - 規模、份額、展望、機會分析，2023-2030 年

細胞表面標記物檢測是使用流式細胞儀等分析技術和流程分離和鑑定目標細胞。 使用流式細胞術等技術的細胞表面標記分析有望簡化疾病分析、樣本分離、疾病診斷和後續治療決策。

市場動態：

與疾病診斷中細胞表面標誌物的使用增加、癌症患病率上升、流式細胞術在幹細胞研究中的採用增加、對精準醫學的需求增加、通量和自動化的增加有關技術進步是預計推動增長的主要因素全球細胞表面標記檢測市場。

例如，2022 年 4 月，血液學、尿液分析和止血領域的自動化工作流程解決方案提供商 Sysmex Europe 獲得了流式細胞儀 XF 的 CE 標誌，表明符合歐洲 IVD 法規和 IVD 應用。- 1600 推出，為流式細胞術實驗室建立完整的解決方案，以幫助自動化和優化工作流程，以達到新的效率水平。

這項研究的主要特點

• 本報告對全球細胞表面標記檢測市場進行了深入分析，提供了以 2022 年為基準年的預測期 (2023-2030) 的市場規模和復合年增長率 (CAGR%)。I在這裡。
• 它還闡明了各個細分市場的潛在創收機會，並描述了該市場具有吸引力的投資建議矩陣。
• 它還提供有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
• 它根據以下參數（包括公司亮點、產品組合、主要亮點、財務業績和戰略）介紹了全球細胞表面標記檢測市場的領先企業。
• 參與這項研究的主要公司包括 Grifols SA、Abbott Laboratories、Sysmex Corporation、Agilent Technologies Inc.、Nexcelom Bioscience、Thermo Fisher Scientific Inc.、Siemens Healthineers、Nihon Kohden Corporation、F. Hoffmann -La Roche Ltd。 、Bio Rad Laboratories Inc.、Becton, Dickinson and Company (BD)、Qiagen NV、Diasorin SpA (Luminex Corporation)、Danaher Corporation (Beckman Coulter Inc.)、IVD Medical Holding Limited (Immucor Inc.) 等。
• 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
• 《全球細胞表面標記物檢測市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球細胞表面標記物檢測市場的各種戰略矩陣來促進決策制定。

內容

第一章調查的目的和前提

• 調查目的
• 先決條件
• 縮寫說明

第二章市場範圍

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 市場概況，按產品分類
  • 市場概況：按應用分類
  • 市場概況：按地區
• 連貫機會圖 (COM)

第 3 章市場動態、法規和趨勢分析

• 市場動態
  • 使用細胞表面標記物進行疾病診斷的人數增加
  • 昂貴的設備和缺乏熟練的專業人員
  • 全球癌症患病率上升
• 影響分析
• 主要亮點
• 監管場景
• 產品發布/批准
• 害蟲分析
• 對 PORTER 的分析
• 合併/收購場景

第 4 章全球細胞表面標記物檢測市場 - 冠狀病毒 (COVID-19) 大流行的影響

• COVID-19 流行病學
• 供應方和需求方分析
• 經濟影響

第 5 章全球細胞表面標記檢測市場，按產品分類，2017-2030

• 流式細胞術
• 血液分析儀
• 細胞成像系統
• 試劑和試劑盒
• 其他產品

第 6 章全球細胞表面標記物檢測市場，按應用，2017-2030

• 疾病診斷與鑑定
• 藥物發現
• 其他 - 研究和學術應用

第 7 章全球細胞表面標記物檢測市場，按地區劃分，2017-2030

• 北美
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東和非洲
• 世界其他地區

第八章競爭格局

• Grifols SA
• Abbott Laboratories
• Sysmex Corporation
• Agilent Technologies Inc.
• Nexcelom Bioscience
• Thermo Fisher Scientific Inc.
• Siemens Healthineers
• Nihon Kohden Corporation
• F. Hoffmann-La Roche Ltd.
• Bio Rad Laboratories Inc.
• Becton, Dickinson and Company（BD）
• Qiagen NV
• Diasorin SpA（Luminex Corporation）
• Danaher Corporation（Beckman Coulter Inc.）
• IVD Medical Holding Limited（Immucor Inc.）

第 9 章

• 調查方法
• 關於出版商

Cell surface markers detection refers to separation and identification of target cells using analytical methods and processes, such as flow cytometry. Cell surface marker analysis through the usage of technologies, such as flow cytometry, is expected to simplify disease analysis, sample separation, disease diagnosis, and subsequent treatment determination.

Market Dynamics:

Rise in use of cell surface markers in disease diagnostics, rise in prevalence of cancer, increasing adoption of flow cytometry in stem cell research, increasing demand for precision medicine, and technological advances related to increased throughput and automation are major factors expected to drive growth of the global cell surface markers detection market.

For instance, in April 2022, Sysmex Europe, a provider of automated workflow solutions in the disciplines of hematology, urinalysis, and hemostasis, launched Flow Cytometer XF-1600 which has received CE marking, indicating its compliance with the European IVD Regulation and IVD use; establishing a complete solution for flow cytometry laboratories to help them automate and optimize their workflow for a new level of efficiency.

Key features of the study:

• This report provides in-depth analysis of the global cell surface markers detection market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global cell surface markers detection market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Grifols SA, Abbott Laboratories, Sysmex Corporation, Agilent Technologies Inc., Nexcelom Bioscience, Thermo Fisher Scientific Inc., Siemens Healthineers, Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd., Bio Rad Laboratories Inc., Becton, Dickinson and Company (BD), Qiagen NV, Diasorin SpA (Luminex Corporation), Danaher Corporation (Beckman Coulter Inc.), and IVD Medical Holding Limited (Immucor Inc.), among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global cell surface markers detection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell surface markers detection market.

Detailed Segmentation:

• Global Cell Surface Markers Detection Market, By Product:
  • Flow Cytometry
  • Hematology Analysers
  • Cell Imaging Systems
  • Reagents and Kits
  • Other Products
• Global Cell Surface Markers Detection Market, By Application:
  • Disease Diagnosis and Identification
  • Drug Discovery
  • Other - Research and Academia Applications
• Global Cell Surface Markers Detection Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles:
  • Grifols SA
  • Abbott Laboratories
  • Sysmex Corporation
  • Agilent Technologies Inc.
  • Nexcelom Bioscience
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers
  • Nihon Kohden Corporation
  • F. Hoffmann-La Roche Ltd.
  • Bio Rad Laboratories Inc.
  • Becton, Dickinson and Company (BD)
  • Qiagen NV
  • Diasorin SpA (Luminex Corporation)
  • Danaher Corporation (Beckman Coulter Inc.)
  • IVD Medical Holding Limited (Immucor Inc.)

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By Application
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rise in use of cell surface markers disease diagnostics
  • High cost of instruments and dearth of skilled professionals
  • Rise in prevalence of cancer worldwide
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Cell Surface Markers Detection Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Cell Surface Markers Detection Market, By Product, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Flow Cytometry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Hematology Analysers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Cell Imaging Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Reagents and Kits
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Other Products
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Cell Surface Markers Detection Market, By Application, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Disease Diagnosis and Identification
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Drug Discovery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
• Other - Research and Academia Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

7. Global Cell Surface Markers Detection Market, By Geography, 2017-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)
• Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Mn)

8. Competitive Landscape

• Grifols SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sysmex Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nexcelom Bioscience
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nihon Kohden Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F. Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio Rad Laboratories Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company (BD)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Qiagen NV
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Diasorin SpA (Luminex Corporation)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Danaher Corporation (Beckman Coulter Inc.)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• IVD Medical Holding Limited (Immucor Inc.)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us